Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone
- 1 February 1999
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 16 (2) , 147-153
- https://doi.org/10.1046/j.1464-5491.1999.00029.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Effects of troglitazone and metformin on glucose and lipid metabolismBiochemical Pharmacology, 1997
- Double-masked, placebo-controlled, dose-ranging study of troglitazone 10 to 200 mg once daily in non—insulin-dependent diabetes mellitusCurrent Therapeutic Research, 1997
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patientsDiabetologia, 1996
- Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured CellsJournal of Biological Chemistry, 1995
- Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and
C57BL KsJ-db db Metabolism, 1995 - A Desktop Guide for the Management of Non‐insulin‐dependent Diabetes Mellitus (NIDDM): An UpdateDiabetic Medicine, 1994
- Sulfonylureas in NIDDMDiabetes Care, 1992
- Biguanides and Sulfonylureas as Combination Therapy in NIDDMDiabetes Care, 1990